Calcitriol improves streptozotocin-induced diabetes and recovers bone mineral density in diabetic rats

Calcified Tissue International

Volumn 75, Issue 6, 2004, Pages 526-532

  Del Pino Montes, J ^b   Benito, G E ^a   Fernandez Salazar M P ^a   Covenas R ^a   Calvo, J J ^a   Bouillon, R ^c   Quesada, J M ^d  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Calcitrol; Diabetes; Insulin; Streptozotocin

Indexed keywords

CALCITRIOL; CALCIUM; GLUCOSE; PHOSPHATE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; LUMBAR VERTEBRA; NONHUMAN; OSTEOLYSIS; PHOSPHATE BLOOD LEVEL; PHOSPHATE URINE LEVEL; PRIORITY JOURNAL; RANDOMIZATION; RAT; STREPTOZOCIN DIABETES; TIBIA;

ANIMALS; BONE DENSITY; BONE DISEASES, METABOLIC; BONE RESORPTION; CALCITRIOL; CALCIUM; DENSITOMETRY, X-RAY; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; LUMBAR VERTEBRAE; PANCREAS; RATS; RATS, WISTAR; TIBIA;

EID: 12944303656     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-004-0118-9     Document Type: Article

References (29)

1. Auwerx J, Dequerker J, Bouillon R, et al. (1988) Mineral metabolism and bone mass at peripheral and axial skeleton in diabetes mellitus. Diabetes 37:8-12
2. Levin ME, Boisseau VC, Avioli LV (1976) Effects of diabetes mellitus on bone mass in juvenile and adult onset diabetes. N Engl J Med 294:241-245
3. 2 Vitamin D on bone mineral density of diabetic rat . Bone 23(Suppl 5):S643
4. Katoh T, Maeda Y, Yamato H, et al. (1988) Effect of 24R, 25-dihydroxyvitamin D3 in experimental diabetic rats. J Int Med Res 164:300-304
5. Verhaeghe J, Suiker AM, Van Bree R, et al. (1993) Increased clearance of 1.25(OH)2D3 and tissue-specific responsiveness to 1.25(OH)2D3 in diabetic rats. Am J Physiol 265(2 Pt 1):E215-E223
6. Reichel H, Koefler HP, Norman AW (1989) The role of the vitamin D endocrine system in health and disease. N Engl J Med 320:980-991
7. 3 metabolism in kidney cell cultures: lack of a direct effect of estradiol. Am J Physiol 20:E119-E124
8. Storm TL, Sorensen OH, Lund B, et al. (1983) Vitamin D metabolism in insulin-dependent diabetes mellitus. Metab Bone Dis Relat Res 5:107-110
9. Verhaeghe J, van Herck E, Visser WJ (1990) Bone and mineral metabolism in BB rats with long-term diabetes.. Decreased bone turnover and osteoporosis. Diabetes 39:477-482
10. Nyomba BL, Bouillon R, Lissens W, et al. (1985) 1.25-Dihydroxyvitamin D and vitamin D-binding protein are both decreased in streptozotocin-diabetic rats. Endocrinology 116:2483-2488
11. Norman AW, Frankel BJ, Heldt AM, Grodsky GM (1980) Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 209:823-825
12. Quesada JM, Martin-Malo A, Santiago J, et al. (1990) Effect of calcitriol on insulin secretion in uraemia. Nephrol Dial Transplant 5:1013-1017
13. Orwoll E, Riddle M, Prince M (1994) Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. Am J Clin Nutr 59:1083-1087
14. 3 and the analogues MC903 and KH1060 on interleukin-1 beta-induced inhibition of rat pancreatic islet beta-cell function in vitro. Immunol Lett 41:73-77
15. 3: preferential inhibition of Th1 functions. J Nutr 125(Suppl):1704S-1708S
16. 3 prevents insulitis in NOD mice. Diabetes 41:1491-1495
17. 3 restores sensitivity to cyclophosphamide-induced apoptosis in non-obese diabetic (NOD) mice and protects against diabetes. Clin Exp Immunol 112:181-187
18. Inaba M, Nishizawa Y, Song K, et al. (1992) Partial protection of 1a-hydroxyvitamin D, against the development of diabetes induced by multiple low dose streptozotocin injection in CD-1 mice. Metabolism 41:630-635
19. Rasch R (1979) Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment. Kidney size and glomerular volume. Diabetologia 162:125-128
20. Mathieu C, Casteels K, Bouillon R (1997) Vitamin D and diabetes. In: Feldman, Glorieux, Pike (eds) Vitamin D Academic Press. Chapter 70, p 1183
21. Rodrigues B, Cam MC, Jian K, et al. (1997) Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity. Diabetes 46:1346-1353
22. Huang S, Hultgren B, Dybdal N, Stewart TA (1994) Islet expression of interferon-alfa precedes diabetes in both the BB rat and streptozotocin-treated mice. Immunity 6:469-478
23. Cockfield SM, Ramassar V, Urmson J, Halloran PF (1989) Multiple lowdose streptozotocin induces systemic MHC expression in mice by triggering T cells to release IFN-γ. J Immunol 142:1120-1128
24. 3: a transcriptional modulator of the interferon-γ gene. Eur J Immunol 28:3017-3030
25. Uchigata Y, Tamamoto H, Nagai H, Okamoto H (1983) Effect of poly (ADP-ribose) synthetase inhibitor administration to rats before and after injection of alloxan and streptozotocin on islet proinsulin synthesis. Diabetes 32:316-318
26. Robbins MJ, Sharp AR, Slonin AE, Burr IM (1980) Protection against streptozotocin-induced diabetes by superoxide dismutase. Diabetologia 18:55-80
27. Tsuji A, Sakurai H (1998) Generation of nitric oxide from streptozotocin (STZ) in the presence of copper(II) plus ascorbate: implication for the development of STZ-induced diabetes. Biochem Biophys Res Commun 245:11-16
28. Verstuyf A, Mathieu C, Verlinden L, et al. (1995) Differentiation induction of human leukemia cells (HL60) by a combination of 1.25-dihydroxyvitamin D3 and retinoic acid (all trans or 9-cis). J Steroid Biochem Mol Biol 531-6:431-441
29. Heberden C, Denis I, Pointillart A, Mercier T (1998) TGF-beta and calcitriol. Gen Pharmacol 302:145-151